HORIZON THERAPEUTICS PUB L's ticker is HZNP and the CUSIP is G46188101. A total of 297 filers reported holding HORIZON THERAPEUTICS PUB L in Q1 2020. The put-call ratio across all filers is 0.97 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $92,552 | -28.2% | 800 | -36.2% | 0.00% | 0.0% |
Q2 2023 | $128,975 | +12.8% | 1,254 | +19.7% | 0.00% | 0.0% |
Q1 2023 | $114,379 | +103.0% | 1,048 | -29.9% | 0.00% | -50.0% |
Q4 2022 | $56,331 | -87.0% | 1,494 | -78.7% | 0.00% | -71.4% |
Q3 2022 | $434,000 | -31.3% | 7,019 | -11.5% | 0.01% | -30.0% |
Q2 2022 | $632,000 | -29.7% | 7,929 | -4.9% | 0.01% | -28.6% |
Q4 2021 | $899,000 | -24.4% | 8,340 | -23.1% | 0.01% | -51.7% |
Q3 2021 | $1,189,000 | +21.8% | 10,850 | +4.1% | 0.03% | +11.5% |
Q2 2021 | $976,000 | +155.5% | 10,425 | +151.2% | 0.03% | +136.4% |
Q1 2021 | $382,000 | +26.9% | 4,150 | +0.7% | 0.01% | +10.0% |
Q4 2020 | $301,000 | +9.1% | 4,121 | +15.9% | 0.01% | 0.0% |
Q3 2020 | $276,000 | -7.4% | 3,556 | -56.9% | 0.01% | -16.7% |
Q4 2019 | $298,000 | +26.8% | 8,253 | -4.4% | 0.01% | +20.0% |
Q3 2019 | $235,000 | +2.2% | 8,630 | -9.8% | 0.01% | -28.6% |
Q2 2019 | $230,000 | – | 9,570 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 6,462,634 | $175,978,000 | 7.18% |
SCOPIA CAPITAL MANAGEMENT LP | 4,221,585 | $114,954,000 | 6.73% |
JW Asset Management, LLC | 270,775 | $7,373,000 | 6.49% |
KOPP INVESTMENT ADVISORS LLC | 104,462 | $2,845,000 | 5.23% |
1492 Capital Management LLC | 171,621 | $4,673,000 | 4.56% |
Avoro Capital Advisors LLC | 4,000,000 | $108,920,000 | 4.54% |
Paulson & Co. | 8,170,700 | $222,488,000 | 4.46% |
Rhenman & Partners Asset Management AB | 1,025,000 | $27,911,000 | 3.50% |
Redwood Investments, LLC | 1,376,066 | $37,470,000 | 2.88% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 218,000 | $5,938,000 | 2.74% |